|
ERI2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.891900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.504810E-01 |
| Normal-vs-Stage2 |
4.778600E-01 |
| Normal-vs-Stage3 |
4.625200E-01 |
| Normal-vs-Stage4 |
7.872800E-01 |
| Stage1-vs-Stage2 |
9.752400E-01 |
| Stage1-vs-Stage3 |
9.483900E-02 |
| Stage1-vs-Stage4 |
8.372200E-01 |
| Stage2-vs-Stage3 |
2.544200E-01 |
| Stage2-vs-Stage4 |
8.949200E-01 |
| Stage3-vs-Stage4 |
4.889200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.664700E-03 |
| Normal-vs-AfricanAmerican |
9.396400E-01 |
| Normal-vs-Asian |
8.239200E-01 |
| Caucasian-vs-AfricanAmerican |
5.043900E-02 |
| Caucasian-vs-Asian |
4.172800E-01 |
| AfricanAmerican-vs-Asian |
8.688600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.323780E-02 |
| Normal-vs-Female |
4.806800E-01 |
| Male-vs-Female |
1.580980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.366200E-01 |
| Normal-vs-Extreme_Weight |
4.328800E-01 |
| Normal-vs-Obese |
2.394800E-01 |
| Normal-vs-Extreme_Obese |
1.252990E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.732600E-01 |
| Normal_Weight-vs-Obese |
3.583800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.337190E-01 |
| Extreme_Weight-vs-Obese |
5.883600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.730220E-01 |
| Obese-vs-Extreme_Obese |
2.266600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.781200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.986000E-02 |
| Normal-vs-Age(61-80Yrs) |
2.051600E-02 |
| Normal-vs-Age(81-100Yrs) |
9.140000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.869000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.810000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.637900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.900800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.304900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.378270E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.564440E-04 |
| Normal-VS-Type2 PRCC |
4.323600E-01 |
| Normal-VS-KIRP CIMP |
1.147630E-01 |
| Normal-VS-Unclassified PRCC |
2.783400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.60850000000745E-05 |
| Type1 PRCC-VS-KIRP CIMP |
9.402500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.367000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.196000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.398420E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.859240E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.784200E-01 |
| Normal-vs-N1 |
9.914200E-01 |
| Normal-vs-N2 |
2.353700E-02 |
| N0-vs-N1 |
7.158200E-01 |
| N0-vs-N2 |
1.171380E-01 |
| N1-vs-N2 |
2.868800E-01 |
|
|
